Treatment of primary axillary hyperhidrosis with a cream formulation of oxybutynin chloride 10

J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e524-e526. doi: 10.1111/jdv.17297. Epub 2021 May 6.

Authors

G Kontochristopoulos¹, V Markantoni², E Agiasofitou¹, E Platsidaki², A Kouris², A Campanati³, A M Offidani³, D Rigopoulos², S Gregoriou²

Affiliations

¹ Department of Dermatology, Andreas Sygros Hospital, Athens, Greece.
² Faculty of Medicine, 1st Department of Dermatology-Venereology, Andreas Sygros Hospital, National and Kapodistrian University of Athens, Athens, Greece.
³ Dermatology Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.

PMID: 33893675
DOI: 10.1111/jdv.17297

No abstract available

Publication types

Letter

MeSH terms

Axilla
Humans
Hyperhidrosis* / drug therapy
Mandelic Acids* / adverse effects
Quality of Life
Treatment Outcome

Substances

Mandelic Acids
oxybutynin